Zafgen (NASDAQ: ZFGN) announced that it received verbal notice late yesterday from the U.S. Food and Drug Administration (FDA) that ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments Trader Talk

RBC Capital Sees Attractive Risk/Reward in Zafgen (ZFGN)October 19, 2015 10:13 AM UPDATE: FBR Downgrades Zafgen (ZFGN) to Sector PerformOctober 16, 2015 2:56 PM Cowen Cuts Price Target on Zafgen (ZFGN) as Beloranib is Placed on Hold Following Patient Death October 16, 2015 1:28 PM Zafgen (ZFGN) PT Cut to $46 at Leerink Partners Amid Partial Clinical Hold; Maintains Bullish ViewOctober 16, 2015 12:07 PM Zafgen Announces Partial Clinical Hold Affecting Beloranib TrialsOctober 16, 2015 6:30 AM